These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20335191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New pharmacotherapy for hepatitis C.
    Assis DN, Lim JK.
    Clin Pharmacol Ther; 2012 Sep; 92(3):294-305. PubMed ID: 22850602
    [Abstract] [Full Text] [Related]

  • 6. Directly acting antivirals against hepatitis C virus.
    Soriano V, Vispo E, Poveda E, Labarga P, Martin-Carbonero L, Fernandez-Montero JV, Barreiro P.
    J Antimicrob Chemother; 2011 Aug; 66(8):1673-86. PubMed ID: 21652618
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R, Fagiuoli S, Sacchi P.
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
    [No Abstract] [Full Text] [Related]

  • 10. [New treatments for hepatitis C, which targets, what timeline?].
    Goossens N, Negro F.
    Rev Med Suisse; 2011 Sep 07; 7(307):1683-8. PubMed ID: 21987876
    [Abstract] [Full Text] [Related]

  • 11. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.
    Rodríguez-Torres M.
    Expert Rev Anti Infect Ther; 2012 Oct 07; 10(10):1117-28. PubMed ID: 23199398
    [Abstract] [Full Text] [Related]

  • 12. [Intolerance to and/or drug interactions of anti-HIV and anti-HVC therapy].
    Galpérine T, Merle C, de Truchis P, Bernard L, Perronne C.
    Med Mal Infect; 2005 Mar 07; 35(3):135-40. PubMed ID: 15911183
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
    Soriano V, Labarga P, Vispo E, Fernández-Montero JV, Barreiro P.
    Infect Dis Clin North Am; 2012 Dec 07; 26(4):931-48. PubMed ID: 23083825
    [Abstract] [Full Text] [Related]

  • 14. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
    Rodríguez-Torres M.
    Curr Opin Infect Dis; 2013 Feb 07; 26(1):50-7. PubMed ID: 23242341
    [Abstract] [Full Text] [Related]

  • 15. [Coinfection with hepatitis C virus and HIV].
    Ruys TA, Reesink HW, Lange JM.
    Ned Tijdschr Geneeskd; 2003 Oct 18; 147(42):2056-60. PubMed ID: 14606352
    [Abstract] [Full Text] [Related]

  • 16. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec 18; (26):5-6. PubMed ID: 11366497
    [Abstract] [Full Text] [Related]

  • 17. Treating hepatitis C in HIV-HCV coinfected patients.
    Tossing G.
    Infection; 2002 Oct 18; 30(5):329-31. PubMed ID: 12420736
    [Abstract] [Full Text] [Related]

  • 18. The era of direct-acting antivirals has begun: the beginning of the end for HCV?
    Vachon ML, Dieterich DT.
    Semin Liver Dis; 2011 Nov 18; 31(4):399-409. PubMed ID: 22189979
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.